NL-OMON21187招募中不适用
ECAP Guided SCS Lead Implantation: an interventional feasibility study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 30
研究概览
简要总结
Planned after completion of the study
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Patient has been included for implantation according to standard criteria from the Dutch Neuromodulation Society.
- •2.Chronic refractory pain as a result of post-laminectomy syndrome (FBSS) for at least 6 months.
- •3.Patient is >18 years old.
- •4.Patient is able and willing to comply with the protocol and follow-up.
- •5.Patient is fluent in the Dutch language.
- •6.Patient is able to provide written informed consent.
排除标准
- •1.Patient is under 18 years old
- •2.Patient is pregnant or nursing
- •3.Patient is unable to operate the EvokeTM SCS System
- •4.Patient is an unsuitable candidate for SCS
研究者
相似试验
已完成
不适用
ECAP Guided SCS Lead Implantation: an interventional feasibility studyNL-OMON49096Sint Antonius Ziekenhuis30
招募中
不适用
EVOKE ECAP-Controlled Lead Placement and Programming in Chronic Pain PatientsBack Pain Lower Back ChronicSpinal Cord StimulationNCT05704751Barts & The London NHS Trust20
已完成
4 期
Quick ICD Study: Is Extensive Electrophysiological Testing Before, During and After ICD-Implantation Still Necessary ?Cardiac ArrestNCT00180362Boston Scientific Corporation200
招募中
不适用
Improving Spinal Cord Stimulation With ECAPSChronic PainNCT04938245University of Minnesota15
已完成
4 期
Study of the Efficacy of Early Intervention With Secukinumab 300 mg s.c. Compared to Narrow-band UVB in Patients With New-onset Moderate to Severe Plaque PsoriasisPlaque PsoriasisNCT03020199Novartis Pharmaceuticals196